Crossmark

An explorative study on deep profiling of peripheral leukocytes to identify predictors for responsiveness to anti-tumour necrosis factor alpha therapies in ankylosing spondylitis: natural killer cells in focus

Crossref DOI link: https://doi.org/10.1186/s13075-018-1692-y

Published Online: 2018-08-29

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schulte-Wrede, Ursula

Sörensen, Till

Grün, Joachim R.

Häupl, Thomas

Hirseland, Heike

Steinbrich-Zöllner, Marta

Wu, Peihua

Radbruch, Andreas

Poddubnyy, Denis

Sieper, Joachim

Syrbe, Uta

Grützkau, Andreas https://orcid.org/0000-0001-6490-2992
Funding

Funding for this research was provided by:

Deutsche Forschungsgemeinschaft (DE) (SFB650 TPZ06)

IMI JU-funded projekt BeTheCure (115-142-2)

Bundesministerium für Bildung und Forschung (DE) (01ZX1306B)

Leibniz-Gemeinschaft (ScienceCampus Chronic Inflammation)
License Information

Text and Data Mining valid from 2018-08-29
More Information

Article History

Received: 27 September 2017

Accepted: 31 July 2018

First Online: 29 August 2018

Ethics approval and consent to participate

: The study was performed in accordance with the 1964 Declaration of Helsinki and approved by the “Charité University Medicine ethics committee I of Charité Campus Mitte”, and all patients provided written informed consent to participate in the study. Furthermore, we declare that this manuscript contains no information or images that could lead to identification of a study participant.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below